Professor - CEO
Ghent University
Sint-Denijs-Westrem, Belgium
Thomas De Beer graduated in pharmaceutical sciences in 2002 at the Ghent University in Belgium. He obtained his PhD at the same university in 2007. For his PhD research, he examined the suitability of Raman spectroscopy as a Process Analytical Technology tool for pharmaceutical production processes. Within his PhD research period, he worked at University of Copenhagen in Denmark, Department of Pharmaceutics and Analytical Chemistry. After his PhD, he was a post-doctoral fellow at the Ghent University (2007-2010). Within his post-doc mandate, he worked 9 months at the Department of Pharmacy, Pharmaceutical Technology and Biopharmaceutics from the LMU in Munich, Germany. In February 2010, he became professor in Process Analytics & Technology at the Faculty of Pharmaceutical Sciences from the Ghent University Ghent. His research goals include bringing innovation pharmaceutical production processes. More specifically, Prof. De Beer contributes to the development of continuous manufacturing processes for drug products such as solids, semi-solids, liquids and biologicals. Thomas De Beer is also director of Ghent University’s Center of Excellence in Sustainable Pharmaceutical Engineering (CESPE) which is founded in 2016. In 2018, Thomas De Beer became co-founder and CEO of RheaVita which provides a continuous freeze-drying technology for the pharmaceutical market.
Disclosure information not submitted.
GMP-Ready Continuous & Controlled Pharmaceutical Freeze-Drying
Monday, October 21, 2024
10:00 AM – 10:30 AM MT